Human papillomavirus (HPV)-related screening technologies and HPV vaccination offer
enormous potential for cancer prevention, notably prevention of cervical cancer. The …

Background Methylation of viral DNA has been proposed as a novel biomarker for triage of
human papillomavirus (HPV) positive women at screening. This systematic review and meta …

Background With the advent of primary human papillomavirus testing followed by cytology
for cervical cancer screening, visual interpretation of cytology slides remains the last …

Importance As cervical cancer screening transitions from Papanicolaou cytologic screening
to primary human papillomavirus (HPV) testing worldwide, effective triage tests are needed …

Importance Cervical cancer is highly preventable but remains a common and deadly cancer
in areas without screening programs. The creation of a diagnostic system to digitize …

Abstract Background: Human papillomavirus (HPV)–based cervical cancer screening
requires triage markers to decide who should be referred to colposcopy. p16/Ki-67 dual …

To evaluate the Turkey's nationwide HPV DNA screening program on the basis of first 1
million screened women. Women over age 30 were invited for population based screening …

BACKGROUND Testing for the presence of the human papillomavirus (HPV) is widely
accepted for triaging Papanicolaou cytology results categorized as atypical squamous cells …

Introduction: The prevalence of cervical Human Papillomavirus (HPV) infection varies
greatly worldwide and data regarding HPV prevalence and genotypes in China are limited …

The policy recommends cytology-based screening every three years from 25 to 30 years of
age, followed by HPV-based screening every five years from 30 to 65 years of age (Exhibit …